JACLYN COLLINS: Open Payments
NPI 1124424536 · YOUNG HARRIS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 35 payments from 12 companies in 2025. Trend: 2023 $157 · 2024 $253 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 6 | $367 |
| Novo Nordisk Inc | 4 | $154 |
| Alnylam Pharmaceuticals Inc. | 1 | $145 |
| ABBVIE INC. | 10 | $135 |
| Otsuka America Pharmaceutical, Inc. | 3 | $82 |
| Exact Sciences Corporation | 2 | $45 |
| Amgen Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Lilly USA, LLC | 1 | $18 |
Products named: Korlym, AMVUTTRA, Ozempic, VRAYLAR, REXULTI, REPATHA, Auvelity, ELIQUIS.
Industry payments across GA — which companies pay providers there.
